Our Management Team
Reny Massoud is a senior executive with over 15 years’ experience delivering sustainable commercial results and strategic partnerships across the corporate and not for profit sectors, in areas ranging from professional services to philanthropy, learning and organisational development to health.
In her most recent role, Reny partnered with clients at CBHS Corporate Health to bring health and wellbeing initiatives to their workplaces, and prior to this, worked with DeakinCo, the corporate education arm of Deakin University, to deliver learning solutions that optimised business results.
Whilst Reny’s career history has been broad and diverse, the common theme has centred on the growth and betterment of people, systems and societal outcomes. She also serves as a member of School Council and the Head of Partnerships and Fundraising at Albert Park College, one of Melbourne’s leading public high schools. Reny holds a Bachelor of Arts degree in Social Sciences and Post-Graduate Diploma in Business.
Education and Communications Officer
Melissa is a scientist, futurist, science communicator, visual and performance artist. Melissa is a graduate of Neuroscience at the University of Melbourne. Melissa is a member of the management committee of Psychedelic Research in Science & Medicine (PRISM) and co-founder of The Australian Psychedelic Society (APS). In 2016, Melissa was co-organiser of The Multidisciplinary Association for Psychedelic Studies (MAPS) most successful ‘Global Fundraiser’, held at The University of Melbourne. In 2018, Melissa was nominated for as an Innovator by VESKI at FastSmarts during Melbourne Knowledge Week. In her role as Education Officer of Mind Medicine Australia, Melissa uses her vision, tenacity, and rational eye to increase awareness of the clinical potential of psychedelic-assisted therapies.
Dr Martin Williams
B.Sc (Hons), MS, Ph.D
Martin Williams, a postdoctoral fellow in Medicinal Chemistry at Monash University, is founding Vice President of Entheogenesis Australia and founding President of Psychedelic Research in Science & Medicine (PRISM). He is also affiliated with Harm Reduction Victoria as a Peer Educator at events and festivals in Victoria. In these various roles, Dr Williams advocates a mature, open discussion about the use of psychoactive plants and chemicals in societies, past and present, and their (increasingly demonstrated) potential to contribute to a more healthy and harmonious future for humanity. With his fellow members of PRISM, he is working to initiate an Australian contribution to the expanding global field of psychedelic medical research. In partnership with St Vincent’s Hospital, PRISM will conduct the first Australian medical trial using psilocybin to ease anxiety and depression for terminally ill patients, supported by Mind Medicine Australia and the Vasudhara Foundation.